CTVA vs NPCE · P/E 42, rev $16.91B vs rev $100.0M
Corteva Inc (CTVA) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Latest reported NPCE revenue for 2025-12-31 was $100.0M. Net income was -$21.5M. Revenue was up 25.1% from 2024-12-31 to 2025-12-31. NPCE currently screens at market cap $312.2M.
CTVA currently screens at market cap $51.52B and trailing P/E 41.6. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the CTVA and NPCE stock pages for the full models.
Not investment advice.